- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 58.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35.8M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 726.67K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.12M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$1.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.81M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $9.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $74.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.48M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $24.27M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $24.44M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $24.35M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $24.44M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.1M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $4.39M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $31.16M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $34.21M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.95 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.95 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.53M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.89M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.61M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.09M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.3M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.89M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $433.4K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$2.58K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $35.66K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $62.79K |
| Revenue | Q1 2026 · Mar 31, 2026 | $469.05K |
| Revenue | Q1 2026 · Mar 31, 2025 | $60.21K |